Groups (n = 8) | Procedures | |
---|---|---|
Control group | 2VO + EMS | |
CPO group | 2VO + EMS with ES treatment | |
CPOMT2A+ NC group | Transfected with LV-NC after 2VO + EMS with ES treatment, then transfected with LV-NC | |
CPOMT2A+ group | 2VO + EMS with ES treatment, then transfected with LV-MT2A | |
CPOMT2A− NC group | 2VO + EMS with ES treatment, then transfected with shRNA NC | |
CPOMT2A− group | 2VO + EMS with ES treatment, then transfected with shRNA-MT2A |